galliium citrate ga68
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jan 15, 2019 (NCT04139395)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05446376 | Phase 2 | Sep 30, 2022 | University of Bordeaux |
| NCT04139395 | Phase 3 | Jan 15, 2019 | Stanford University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Bordeaux | Academic/Hospital | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1